|
⚲
|
| Keyboard |
| Williams Lewis T
✚
|
|
|---|---|
| CIK # | 0001475714 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001475714] | |
| 4 | [0001475714] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Williams Lewis T | |
| Protagonist Therapeutics Inc | |
| Arcellx Inc | |
| Aquinox Pharmaceuticals Inc | |
| Five Prime Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Protagonist Therapeutics Inc PTGX
Stock Option (right to buy) · derivative
|
2026-02-17 | Option exercise | 18,000 | $0.00 | |
|
Protagonist Therapeutics Inc PTGX
Common Stock
|
2026-02-17 | Option exercise | 18,000 | $10.84 | 195,120 |
|
Protagonist Therapeutics Inc PTGX
Common Stock
|
2026-02-17 | Sell | 18,000 | $82.42 | 1,483,560 |
|
Protagonist Therapeutics Inc PTGX
Stock Option (right to buy) · derivative
|
2026-01-02 | Grant | 3,762 | $0.00 | |
|
Protagonist Therapeutics Inc PTGX
Common Stock
|
2026-01-02 | Grant | 2,695 | $0.00 | |
|
Protagonist Therapeutics Inc PTGX
Stock Option (right to buy) · derivative
|
2025-01-02 | Grant | 6,584 | $0.00 | |
|
Protagonist Therapeutics Inc PTGX
Common Stock
|
2025-01-02 | Grant | 5,130 | $0.00 | |
|
Protagonist Therapeutics Inc PTGX
Stock Option (right to buy) · derivative
|
2024-01-02 | Grant | 25,700 | $0.00 | |
|
Protagonist Therapeutics Inc PTGX
Stock Option (right to buy) · derivative
|
2023-01-16 | Grant | 30,000 | $0.00 | |
|
Protagonist Therapeutics Inc PTGX
Stock Option (right to buy) · derivative
|
2022-05-26 | Grant | 20,000 | $0.00 | |
|
Arcellx Inc ACLX
Common Stock
|
2022-02-08 | Conversion | 2,095,114 | $0.00 | |
|
Arcellx Inc ACLX
Series B-2 Preferred Stock · derivative
|
2022-02-08 | Conversion | 931,228 | $0.00 | |
|
Arcellx Inc ACLX
Series B-1 Preferred Stock · derivative
|
2022-02-08 | Conversion | 1,163,886 | $0.00 | |
|
Protagonist Therapeutics Inc PTGX
Stock Option (right to buy) · derivative
|
2021-05-27 | Grant | 18,000 | $0.00 | |
|
Aquinox Pharmaceuticals Inc NLTX
Stock Option (Right to Buy) · derivative
|
2021-05-11 | Grant | 25,000 | $0.00 | |
|
Protagonist Therapeutics Inc PTGX
Stock Option (right to buy) · derivative
|
2020-05-28 | Grant | 15,000 | $0.00 | |
|
Aquinox Pharmaceuticals Inc NLTX
Stock Option (Right to Buy) · derivative
|
2020-05-05 | Grant | 25,000 | $0.00 | |
|
Aquinox Pharmaceuticals Inc NLTX
Stock Option (right to buy) · derivative
|
2019-10-10 | Grant | 22,000 | $0.00 | |
|
Five Prime Therapeutics Inc FPRX
Common Stock
|
2019-09-01 | Tax withheld | 7,024 | $5.43 | 38,140 |
|
Five Prime Therapeutics Inc FPRX
Stock Option (right to buy) · derivative
|
2019-06-10 | Grant | 15,000 | $0.00 | |
| showing 20 of 112 most recent transactions | |||||